These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
490 related articles for article (PubMed ID: 30033559)
21. The potential impact of pre-exposure prophylaxis for HIV prevention among men who have sex with men and transwomen in Lima, Peru: a mathematical modelling study. Gomez GB; Borquez A; Caceres CF; Segura ER; Grant RM; Garnett GP; Hallett TB PLoS Med; 2012; 9(10):e1001323. PubMed ID: 23055836 [TBL] [Abstract][Full Text] [Related]
22. Epidemiological impact and cost-effectiveness of providing long-acting pre-exposure prophylaxis to injectable contraceptive users for HIV prevention in South Africa: a modelling study. van Vliet MM; Hendrickson C; Nichols BE; Boucher CA; Peters RP; van de Vijver DA J Int AIDS Soc; 2019 Dec; 22(12):e25427. PubMed ID: 31855323 [TBL] [Abstract][Full Text] [Related]
23. Cost-effectiveness of easy-access, risk-informed oral pre-exposure prophylaxis in HIV epidemics in sub-Saharan Africa: a modelling study. Phillips AN; Bershteyn A; Revill P; Bansi-Matharu L; Kripke K; Boily MC; Martin-Hughes R; Johnson LF; Mukandavire Z; Jamieson L; Meyer-Rath G; Hallett TB; Ten Brink D; Kelly SL; Nichols BE; Bendavid E; Mudimu E; Taramusi I; Smith J; Dalal S; Baggaley R; Crowley S; Terris-Prestholt F; Godfrey-Faussett P; Mukui I; Jahn A; Case KK; Havlir D; Petersen M; Kamya M; Koss CA; Balzer LB; Apollo T; Chidarikire T; Mellors JW; Parikh UM; Godfrey C; Cambiano V; Lancet HIV; 2022 May; 9(5):e353-e362. PubMed ID: 35489378 [TBL] [Abstract][Full Text] [Related]
24. Scaling up of HIV treatment for men who have sex with men in Bangkok: a modelling and costing study. Zhang L; Phanuphak N; Henderson K; Nonenoy S; Srikaew S; Shattock AJ; Kerr CC; Omune B; van Griensven F; Osornprasop S; Oelrichs R; Ananworanich J; Wilson DP Lancet HIV; 2015 May; 2(5):e200-7. PubMed ID: 26423002 [TBL] [Abstract][Full Text] [Related]
25. Preexposure prophylaxis for men who have sex with men in the Netherlands: impact on HIV and Neisseria gonorrhoeae transmission and cost-effectiveness. Reitsema M; Hoek AJV; van der Loeff MS; Hoornenborg E; van Sighem A; Wallinga J; van Benthem B; Xiridou M AIDS; 2020 Mar; 34(4):621-630. PubMed ID: 31895142 [TBL] [Abstract][Full Text] [Related]
26. Implementation and Operational Research: A Cost-Effective, Clinically Actionable Strategy for Targeting HIV Preexposure Prophylaxis to High-Risk Men Who Have Sex With Men. Ross EL; Cinti SK; Hutton DW J Acquir Immune Defic Syndr; 2016 Jul; 72(3):e61-7. PubMed ID: 26977749 [TBL] [Abstract][Full Text] [Related]
27. Cost-effectiveness and budget effect of pre-exposure prophylaxis for HIV-1 prevention in Germany from 2018 to 2058. van de Vijver DAMC; Richter AK; Boucher CAB; Gunsenheimer-Bartmeyer B; Kollan C; Nichols BE; Spinner CD; Wasem J; Schewe K; Neumann A Euro Surveill; 2019 Feb; 24(7):. PubMed ID: 30782266 [TBL] [Abstract][Full Text] [Related]
28. Pre-exposure prophylaxis (PrEP) for MSM in low HIV incidence places: should high risk individuals be targeted? Wong NS; Kwan TH; Tsang OTY; Lee MP; Yam WC; Lam W; Leung WS; Chan JMC; Ho KM; Lee SS Sci Rep; 2018 Aug; 8(1):11641. PubMed ID: 30076362 [TBL] [Abstract][Full Text] [Related]
29. HIV pre-exposure prophylaxis and early antiretroviral treatment among female sex workers in South Africa: Results from a prospective observational demonstration project. Eakle R; Gomez GB; Naicker N; Bothma R; Mbogua J; Cabrera Escobar MA; Saayman E; Moorhouse M; Venter WDF; Rees H; PLoS Med; 2017 Nov; 14(11):e1002444. PubMed ID: 29161256 [TBL] [Abstract][Full Text] [Related]
30. Modelling impact and cost-effectiveness of oral pre-exposure prophylaxis in 13 low-resource countries. Pretorius C; Schnure M; Dent J; Glaubius R; Mahiane G; Hamilton M; Reidy M; Matse S; Njeuhmeli E; Castor D; Kripke K J Int AIDS Soc; 2020 Feb; 23(2):e25451. PubMed ID: 32112512 [TBL] [Abstract][Full Text] [Related]
31. The effect of combination prevention strategies on HIV incidence among gay and bisexual men who have sex with men in the UK: a model-based analysis. Cambiano V; Miners A; Lampe FC; McCormack S; Gill ON; Hart G; Fenton KA; Cairns G; Thompson M; Delpech V; Rodger AJ; Phillips AN Lancet HIV; 2023 Nov; 10(11):e713-e722. PubMed ID: 37923485 [TBL] [Abstract][Full Text] [Related]
32. A Cost-effectiveness Analysis of Preexposure Prophylaxis for the Prevention of HIV Among Los Angeles County Men Who Have Sex With Men. Drabo EF; Hay JW; Vardavas R; Wagner ZR; Sood N Clin Infect Dis; 2016 Dec; 63(11):1495-1504. PubMed ID: 27558571 [TBL] [Abstract][Full Text] [Related]
33. Protocol for a multicenter, real-world study of HIV pre-exposure prophylaxis among men who have sex with men in China (CROPrEP). Wang H; Zhang Y; Mei Z; Jia Y; Leuba SI; Zhang J; Chu Z; Ding H; Jiang Y; Geng W; Shang H; Xu J BMC Infect Dis; 2019 Aug; 19(1):721. PubMed ID: 31416439 [TBL] [Abstract][Full Text] [Related]
34. Potential Impact of Targeted HIV Pre-Exposure Prophylaxis Uptake Among Male Sex Workers. Goedel WC; Mimiaga MJ; King MRF; Safren SA; Mayer KH; Chan PA; Marshall BDL; Biello KB Sci Rep; 2020 Mar; 10(1):5650. PubMed ID: 32221469 [TBL] [Abstract][Full Text] [Related]
35. Implementation of a Test, Treat, and Prevent HIV program among men who have sex with men and transgender women in Thailand, 2015-2016. Ongwandee S; Lertpiriyasuwat C; Khawcharoenporn T; Chetchotisak P; Thiansukhon E; Leerattanapetch N; Leungwaranan B; Manopaiboon C; Phoorisri T; Visavakum P; Jetsawang B; Poolsawat M; Nookhai S; Vasanti-Uppapokakorn M; Karuchit S; Kittinunvorakoon C; Mock P; Prybylski D; Sukkul AC; Roels T; Martin M PLoS One; 2018; 13(7):e0201171. PubMed ID: 30044867 [TBL] [Abstract][Full Text] [Related]
36. The cost-effectiveness of preexposure prophylaxis for HIV prevention in the United States in men who have sex with men. Juusola JL; Brandeau ML; Owens DK; Bendavid E Ann Intern Med; 2012 Apr; 156(8):541-50. PubMed ID: 22508731 [TBL] [Abstract][Full Text] [Related]
37. A novel method to estimate the indirect community benefit of HIV interventions using a microsimulation model of HIV disease. Kazemian P; Costantini S; Neilan AM; Resch SC; Walensky RP; Weinstein MC; Freedberg KA J Biomed Inform; 2020 Jul; 107():103475. PubMed ID: 32526280 [TBL] [Abstract][Full Text] [Related]
38. Evaluating the potential impact and cost-effectiveness of dapivirine vaginal ring pre-exposure prophylaxis for HIV prevention. Reidy M; Gardiner E; Pretorius C; Glaubius R; Torjesen K; Kripke K PLoS One; 2019; 14(6):e0218710. PubMed ID: 31242240 [TBL] [Abstract][Full Text] [Related]
39. Acceptability of pre-exposure prophylaxis for HIV prevention: facilitators, barriers and impact on sexual risk behaviors among men who have sex with men in Benin. Ahouada C; Diabaté S; Mondor M; Hessou S; Guédou FA; Béhanzin L; Batona G; Gning NN; Zannou DM; Alary M BMC Public Health; 2020 Aug; 20(1):1267. PubMed ID: 32819335 [TBL] [Abstract][Full Text] [Related]
40. Predicted effects of the introduction of long-acting injectable cabotegravir pre-exposure prophylaxis in sub-Saharan Africa: a modelling study. Smith J; Bansi-Matharu L; Cambiano V; Dimitrov D; Bershteyn A; van de Vijver D; Kripke K; Revill P; Boily MC; Meyer-Rath G; Taramusi I; Lundgren JD; van Oosterhout JJ; Kuritzkes D; Schaefer R; Siedner MJ; Schapiro J; Delany-Moretlwe S; Landovitz RJ; Flexner C; Jordan M; Venter F; Radebe M; Ripin D; Jenkins S; Resar D; Amole C; Shahmanesh M; Gupta RK; Raizes E; Johnson C; Inzaule S; Shafer R; Warren M; Stansfield S; Paredes R; Phillips AN; Lancet HIV; 2023 Apr; 10(4):e254-e265. PubMed ID: 36642087 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]